Results date: 29 August 2013
Oxford, UK – 23 July 2013: Oxford BioMedica plc (“Oxford BioMedica” or “the Company”) (LSE: Oxford Biomedica), the leading gene-based biopharmaceutical company, will be announcing its interim results for the six months ended 30 June 2013 on Thursday, 29 August 2013.
An analyst briefing will be held at 09:30am GMT on Thursday, 29 August 2013 at the offices of M:Communications, 11th Floor, CityPoint, 1 Ropemaker Street, London, EC2Y 9AW. An audio replay will be made available shortly after the presentation on the Company’s website: www.oxfordbiomedica.co.uk.
-Ends-